Guidance

7 Sources of evidence considered by the committee

7 Sources of evidence considered by the committee

The diagnostics assessment report was prepared by the School of Health and Related Research (ScHARR), University of Sheffield.

  • Stevenson M, Pandor A, Martyn‑St James M et al. Sepsis: The LightCycler SeptiFast Test MGRADE, SepsiTest and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi. A systematic review and economic evaluation. July 2015.

Registered stakeholders

The following organisations accepted the invitation to participate in this assessment as registered stakeholders. They were invited to attend the scoping workshop and to comment on the diagnostics assessment report and the diagnostics consultation document.

Manufacturers of technologies included in the final scope:

  • Abbott Laboratories

  • Roche Diagnostics

  • Molzym

Other commercial organisations:

  • Alacrita LLP

  • Anagnostics

  • Hain Lifescience UK Ltd

Professional groups and patient/carer groups:

  • Group B Strep Support

  • UK Sepsis Trust

Research groups:

None

Associated guideline groups:

  • National Clinical Guidelines Centre

Others:

  • Department of Health

  • Healthcare Improvement Scotland

  • NHS England

  • Welsh Government